Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
718studies shown
Showing 1-12 of 718
Drug study icon
RecruitingNCT04478838

"Extended" (Alternate Day) Antipsychotic Dosing

This study is recruiting. It focuses on schizophrenia and currently lists participation information in Canada.

In Toronto
SchizophreniaOtherOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
Other study type icon
RecruitingNCT07493551

A Bioequivalence Study of PP3M in people with Schizophrenia

This study is recruiting. It focuses on schizophrenia and currently lists participation information in China.

In Beijing
SchizophreniaOtherFrom 18 Years to 65 Years
Countries
China
Sponsor
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Condition
Schizophrenia
Other study type icon
RecruitingISRCTN16326066

A brief imagery intervention for future-oriented mental images

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.

In United Kingdom
SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
Oxford Health NHS Foundation Trust
Condition
Schizophrenia
Drug study icon
RecruitingISRCTN79796233

A study to investigate how effective a stimulant medication is compared to a non-stimulant medication in patients who have been diagnosed with attention deficit hyperactivity disorder (ADHD) and also have a history of either psychosis or Bipolarity

This study is recruiting in the United Kingdom. It focuses on ADHD.

In United Kingdom
Bipolarity, ADHD, ...OtherFrom 18 Years to 100 Years
Countries
United Kingdom
Sponsor
University of Birmingham
Condition
Bipolarity, ADHD, ...
Device study icon
RecruitingISRCTN72210184

Double-blind randomised controlled trial of repetitive Transcranial Magnetic Stimulation in the treatment of persistent auditory hallucinations for schizophrenia

This study is recruiting in the United Kingdom. It is testing double-blind randomised controlled trial of repetitive Transcranial Magnetic Stimulation in the treatment of persistent auditory hallucinations for schizophrenia.

In United Kingdom
SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
Department of Health (UK)
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.